Tuberculosis remains a significant global health challenge, with millions affected each year. Understanding how many people died of tuberculosis helps public health leaders prioritize resources and save more lives.
This article provides data, trends, and context across key themes to clarify the impact of TB worldwide.
| Region | 2022 TB Deaths | 2023 TB Deaths | Change from 2022 to 2023 |
|---|---|---|---|
| Africa | 410,000 | 390,000 | -4.9% |
| South-East Asia | 320,000 | 300,000 | -6.3% |
| Western Pacific | 150,000 | 140,000 | -6.7% |
| Eastern Mediterranean | 85,000 | 80,000 | -5.9% |
| Americas and Europe | 35,000 | 32,000 | -8.6% |
Global Tuberculosis Mortality Trends
Progress and Persistent Burden
Over the past decade, global efforts have reduced how many people died of tuberculosis through early detection and treatment. Yet in 2023, hundreds of thousands still lost their lives to TB, highlighting the gap in care and financing.
High-burden countries see uneven progress, with declines in some areas and increases in others due to conflict, migration, and weak health systems.
Impact of COVID-19 on TB Services
The pandemic disrupted diagnosis, treatment, and reporting, causing a temporary rise in how many people died of tuberculosis in some regions. Service recovery continues, but many lives were lost during the disruption window.
High-Risk Populations and Settings
People Living with HIV and TB
Co-infection drives a large share of TB deaths, especially where HIV prevalence is high. People living with HIV are more likely to develop active TB and to die without timely care.
Refugees, Migrants, and Informal Settlements
Overcrowding, limited access to care, and stigma increase mortality among displaced populations. In these settings, tracking how many people died of tuberculosis is challenging but essential for targeted interventions.
Prevention, Treatment, and System Response
Early Detection and Care Continuum
Rapid diagnosis and consistent treatment reduce both transmission and deaths. Strengthening community-based services helps lower how many people died of tuberculosis in hard-to-reach areas.
Drug-Resistant TB and Regimen Outcomes
MDR-TB and XDR-TB remain deadly without longer, more complex regimens. Investment in shorter regimens and patient support is critical to improving survival.
Path Forward for TB Control
- Expand access to rapid diagnostics and quality treatment for all TB patients.
- Strengthen integration of TB and HIV services to reduce co-infection deaths.
- Invest in community health workers to improve case-finding in high-risk and displaced populations.
- Accelerate development and rollout of shorter, safer regimens for drug-resistant TB.
- Increase domestic and international financing to close the gap in TB care and prevention.
FAQ
Reader questions
Which region recorded the largest decline in TB deaths between 2022 and 2023?
Americas and Europe recorded the largest decline at -8.6%, reflecting stronger health system recovery and higher treatment completion rates.
How many people died of tuberculosis among those living with HIV in 20 TB-affected countries?
Data from those countries indicate that a substantial share of TB deaths occurred among people living with HIV, often due to late diagnosis and limited antiretroviral coverage.
What role did the COVID-19 pandemic play in TB mortality trends?
Disruptions to testing, reporting, and treatment led to a temporary increase in how many people died of tuberculosis in several regions during 2020 and 2021.
Are multidrug-resistant TB cases associated with higher death rates?
Yes, without timely access to appropriate second-line drugs, MDR-TB and XDR-TB case-fatality rates remain significantly higher than for drug-susceptible TB.